# OnCo record vironexis-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/vironexis-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "vironexis-biotherapeutics" ;
  schema:name "Vironexis Biotherapeutics"@en ;
  schema:alternateName "Vironexis Biotherapeutics Inc."@en ;
  schema:description "Vironexis Biotherapeutics is a US-based biotechnology company that leads 2 cancer trials in OnCo, testing the AAV-delivered T-cell engager gene therapies VNX-101 and VNX-202 in acute lymphoblastic leukaemia, diffuse large B-cell lymphoma, chronic lymphocytic leukaemia, non-Hodgkin lymphoma and advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/vironexis-biotherapeutics/>, <https://vironexis.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://vironexis.com>, <https://clinicaltrials.gov/search?lead=Vironexis%20Biotherapeutics%20Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:trials <https://onco.cc/trials/nct06533579/>, <https://onco.cc/trials/nct07192432/> .